Logo image of BIMI

BIMI INTERNATIONAL MEDICAL I (BIMI) Stock Fundamental Analysis

NASDAQ:BIMI - Nasdaq - US05552Q3011 - Common Stock - Currency: USD

0.31  -0.17 (-35.42%)

After market: 0.3115 +0 (+0.48%)

Fundamental Rating

1

Overall BIMI gets a fundamental rating of 1 out of 10. We evaluated BIMI against 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BIMI have multiple concerns. BIMI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BIMI has reported negative net income.
BIMI had a negative operating cash flow in the past year.
In the past 5 years BIMI always reported negative net income.
In the past 5 years BIMI always reported negative operating cash flow.
BIMI Yearly Net Income VS EBIT VS OCF VS FCFBIMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M

1.2 Ratios

BIMI's Return On Assets of -30.51% is on the low side compared to the rest of the industry. BIMI is outperformed by 83.48% of its industry peers.
BIMI's Return On Equity of -122.77% is on the low side compared to the rest of the industry. BIMI is outperformed by 77.39% of its industry peers.
Industry RankSector Rank
ROA -30.51%
ROE -122.77%
ROIC N/A
ROA(3y)-54.49%
ROA(5y)-50.22%
ROE(3y)-292.5%
ROE(5y)-218.85%
ROIC(3y)N/A
ROIC(5y)N/A
BIMI Yearly ROA, ROE, ROICBIMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300 -400 -500

1.3 Margins

With a decent Gross Margin value of 41.01%, BIMI is doing good in the industry, outperforming 69.57% of the companies in the same industry.
In the last couple of years the Gross Margin of BIMI has grown nicely.
The Profit Margin and Operating Margin are not available for BIMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%
BIMI Yearly Profit, Operating, Gross MarginsBIMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K -2.5K

More info and screens

2

2. Health

2.1 Basic Checks

BIMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BIMI has more shares outstanding
BIMI has a better debt/assets ratio than last year.
BIMI Yearly Shares OutstandingBIMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M
BIMI Yearly Total Debt VS Total AssetsBIMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

BIMI has an Altman-Z score of -3.03. This is a bad value and indicates that BIMI is not financially healthy and even has some risk of bankruptcy.
BIMI has a worse Altman-Z score (-3.03) than 86.09% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that BIMI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.13, BIMI is in the better half of the industry, outperforming 73.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -3.03
ROIC/WACCN/A
WACC5.72%
BIMI Yearly LT Debt VS Equity VS FCFBIMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

BIMI has a Current Ratio of 1.21. This is a normal value and indicates that BIMI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BIMI (1.21) is comparable to the rest of the industry.
A Quick Ratio of 0.86 indicates that BIMI may have some problems paying its short term obligations.
BIMI's Quick ratio of 0.86 is on the low side compared to the rest of the industry. BIMI is outperformed by 69.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.86
BIMI Yearly Current Assets VS Current LiabilitesBIMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

BIMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.66%, which is quite impressive.
BIMI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.31%.
The Revenue has been growing slightly by 6.81% on average over the past years.
EPS 1Y (TTM)96.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.72%
Revenue 1Y (TTM)14.31%
Revenue growth 3Y319.71%
Revenue growth 5Y6.81%
Sales Q2Q%-65.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BIMI Yearly Revenue VS EstimatesBIMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BIMI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIMI Price Earnings VS Forward Price EarningsBIMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIMI Per share dataBIMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BIMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIMI INTERNATIONAL MEDICAL I

NASDAQ:BIMI (8/21/2024, 8:07:30 PM)

After market: 0.3115 +0 (+0.48%)

0.31

-0.17 (-35.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)06-24 2024-06-24/amc
Earnings (Next)11-25 2024-11-25
Inst Owners0.16%
Inst Owner Change0%
Ins Owners210.74%
Ins Owner Change0%
Market Cap2.07M
Analysts0
Price TargetN/A
Short Float %4.88%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 0.5
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.73
BVpS0.62
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.51%
ROE -122.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.01%
FCFM N/A
ROA(3y)-54.49%
ROA(5y)-50.22%
ROE(3y)-292.5%
ROE(5y)-218.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y8.8%
F-Score6
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.86
Altman-Z -3.03
F-Score6
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.31%
Revenue growth 3Y319.71%
Revenue growth 5Y6.81%
Sales Q2Q%-65.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.35%
OCF growth 3YN/A
OCF growth 5YN/A